Lactalis

Understanding and Reducing the Water Footprint of Pharmaceutical Lactose: The Lactalis Ingredients Pharma Approach We organized an exclusive Q&A session...

The pharmaceutical industry continues to evolve under the pressure of medication affordability, regulatory constraints, and growing environmental expectations. In 2025,...

PRESS RELEASE Producing Pharmaceutical-Grade Lactose: Lactalis’ Energy Challenges and Environmental Commitments We organized an exclusive Q&A session with Maeva Croué — CSR Coordinator for Lactalis...

From Milk to Medicine: 100 Years of Pharmaceutical Lactose continuous improvement For more than a century, lactose has quietly shaped...

Pharmaceutical Excipient Safety: Exploring Endotoxin Risks in Lactose: A Perspective from Lactalis Ingredients Pharma At Lactalis Ingredients Pharma, we specialize in milled...

Abstract Microwave-induced in situ amorphization is an innovative technology that enables the direct preparation of amorphous solid dispersions (ASDs) in the final...

Lactalis Group, world’s leader of the dairy industry Lactalis Ingredients Pharma arises from the rich history of Lactalis Group, starting...

This year CPHI Europe opens its doors in Frankfurt at Messe Frankfurt. From 28th to 30th October you can have...

Lactose is used as a diluent or a binder depending on the galenics in the pharmaceutical industry. It has been...

The healthcare sector accounts for 4.4% of the world’s net global greenhouse emissions and 8% of emissions in France. Given this...